Biotech raises $90M to take age-related disease drugs into clinical trials
December 18, 2020 at 09:08 AM EST
One of the company's drugs also could be tested as a Covid-19 treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.